Denali Therapeutics Inc. buy BiotechBee
Start price
08.09.24
/
70%
€23.00
Target price
30.05.27
€31.00
Performance (%)
-4.35%
End price
14.12.24
€22.00
Summary
This prediction ended on 14.12.24 with a price of €22.00. With a performance of -4.35%, the BUY prediction by BiotechBee finished with a loss. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Denali Therapeutics Inc. | -12.990% | -12.990% | 49.144% |
| iShares Core DAX® | 1,60 % | -7,45 % | 3,04 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % | 15,42 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % | 34,31 % |
| iShares S&P 500 | -0,39 % | -2,34 % | 9,91 % |
According to BiotechBee what are the pros and cons of Denali Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year